Remus Pharmaceuticals Ltd
NSE: REMUS
₹925.00
₹14.85
(1.63%)
As on 28-Aug-2026IST
Market cap
₹1,090 Cr
Revenue (TTM)
₹620 Cr
P/E Ratio
29.5
P/B Ratio
3.1
Div. Yield
0.1 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹38 Cr
-
ROE
18.6 %
-
ROCE
21.9 %
-
Industry P/E
39.7
-
EV/EBITDA
17.4
-
Debt to Equity
0.1
-
Book Value
₹217.2
-
EPS
₹24.7
-
Face value
10
-
Shares outstanding
11,784,000
6 Years Aggregate
CFO
₹22.82 Cr
EBITDA
₹90.49 Cr
Net Profit
₹76.47 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
REMUS
| 31.7 | 28.3 | 29.8 | -0.4 | 17.9 | -- | -- |
|
BSE Healthcare
| 18.8 | 2.8 | 8.7 | 17.1 | 23.1 | 14.8 | 12.4 |
|
Company
|
2025
|
2024
|
|---|---|---|
|
REMUS
| -43.5 | 33.7 |
|
BSE Small Cap
| -6.6 | 29.0 |
|
BSE Healthcare
| -3.3 | 43.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
REMUS
|
925.0 | 1,090.0 | 620.4 | 38.4 | -- | 18.6 | 29.5 | 3.1 |
| 3,281.6 | 26,870.9 | 1,461.8 | 387.4 | 34.5 | 25.2 | 69.6 | 15.5 | |
| 813.5 | 16,000.2 | 7,784.0 | 688.5 | 10.6 | 14 | 23.1 | 2.7 | |
| 449.9 | 17,241.8 | 2,141.5 | 58.5 | 5.8 | 3.3 | 162.3 | 4.5 | |
| 836.7 | 20,739.4 | 5,632.3 | 662.4 | 17.2 | 14.3 | 31.3 | 4.2 | |
| 1,532.2 | 17,579.4 | 1,543.3 | -48.6 | 3.6 | -0.6 | -- | 3.0 | |
| 218.7 | 29,103.3 | 9,205.3 | -371.8 | 1.7 | -3.8 | -- | 3.6 | |
| 1,804.4 | 29,891.8 | 1,935.8 | 288.2 | 20.6 | 29.8 | 103.7 | 22.3 | |
| 403.4 | 16,284.0 | 3,600.2 | 221.0 | 9.7 | 5.6 | 73.7 | 3.4 | |
| 1,977.1 | 32,103.6 | 3,564.0 | 414.0 | 15.3 | 8.4 | 78.5 | 6.4 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About REMUS
Manufacture of pharmaceuticals, medicinal chemical and botanical products
-
Incorporated
2015
-
Chairman
Swapnil Jatinbhai Shah
-
Managing Director
Arpit Deepakkumar Shah
-
Headquarters
Ahmedabad, Gujarat
-
Website
Looking for more details about Remus Pharmaceuticals Ltd’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for REMUS
What is the current share price of Remus Pharmaceuticals Ltd Today?
The share price of Remus Pharmaceuticals Ltd is ₹925.00 (NSE) as of 28-Aug-2026 IST. Remus Pharmaceuticals Ltd has given a return of 17.89% in the last 3 years.
What is the current PB & PE ratio of Remus Pharmaceuticals Ltd?
The P/E ratio of Remus Pharmaceuticals Ltd is 29.47 times as on 28-Aug-2026, a 26 discount to its peers’ median range of 39.70 times.
The P/B ratio of Remus Pharmaceuticals Ltd is 3.11 times as on 28-Aug-2026, a 16 discount to its peers’ median range of 3.72 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
22.68 |
5.15 |
2024 |
6.18 |
6.43 |
2023 |
0.00 |
0.00 |
2022 |
0.00 |
0.00 |
2021 |
0.00 |
0.00 |
What is the 52 Week High and Low of Remus Pharmaceuticals Ltd?
The 52-week high and low of Remus Pharmaceuticals Ltd are Rs 987.50 and Rs 580.00 as of 31-Aug-2026.
What is the market cap of Remus Pharmaceuticals Ltd?
Remus Pharmaceuticals Ltd has a market capitalisation of ₹ 1,090 Cr as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Remus Pharmaceuticals Ltd?
Before investing in Remus Pharmaceuticals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.